Opdivo is one of several medications that is helping people who've been diagnosed to live longer, more comfortable lives. Non-small cell lung cancer is one of the most common types of lung cancer, with more than 200,000 reported cases every year. Still, if you’ve been diagnosed with lung cancer, it’s important to know that there is treatment available to you. These days there are a number of different options to explore that can help you. Opdivo, a prescription medication, can help individuals with advanced forms of non-small cell lung cancer. The other top lung cancer medications are Keytruda, Imfinzi, Tagrisso, Erbitux and Zykadia. Whether your doctor has told you about Opdivo or these other lung cancer treatments already, or whether you are hearing about these for the first time, here are some facts you should be aware of.
Opdivo is a lung cancer medication that works by redirecting the actions of your immune system. Instead of attacking only viruses and infection, Opdivo redirects the immune system to attack cancer cells, thereby killing cancer cells and potentially ridding the body of cancer or at the very least delaying the rate of cancer growth.
What is Zykadia
Zykadia, or ceritinib in its generic form, is a form of targeted drug therapy designed to hone in on specific surface traits of cancer cells. By interacting with cancer cells, this drug blocks the ability of cancer cells to multiply.
What is Avastin?
Avastin, or bevacizumab in its generic form, is targeted therapy drug similar to Zykadia. This monoclonal antibody targets a cellular protein responsible for the formation of blood vessels. By stopping this process, Avastin helps slow the growth and spread of lung cancer.
What is Imfinzi?
Imfinzi, or durvalumab in its generic form, is a checkpoint inhibitor drug that cripples the ability of cancer cells to evade the immune system's white blood cells.
What is Tagrisso?
Tagrisso, or osimertinib in its generic form, is an EGFR-blocking drug that that prevents cancerous cells and tumors from growing by interrupting a vital protein signal. This drug is capable of remaining effective even against lung cancer cells that undergo the T790M mutation.
What is Keytruda?
Keytruda, or pembrolizumab in its generic form, is an immunotherapy drug that's been approved as an initial treatment for inoperable non-small cell lung cancer. It is administered intravenously.
What is Erbitux?
Erbitux, or cetuximab in its generic form, is another EGFR-blocking drug that slows the growth rate of cancer cells and tumors. For lung cancer patients, Erbitux is sometimes prescribed alongside traditional chemotherapy.
What is Tafinlar?
Tafinlar, or dabrafenib in its generic form, is a BRAF inhibitor that interrupts a cell's ability to grow. The targetted cellular growth process is present in some forms of non-small cell lung cancer, allowing this medication to spare damage to normal, healthy cells.